Yip's Chemical Holdings AI Stock Analysis
Want to see HK:0408 full AI Analyst Report?
Yip's Chemical Holdings (0408) AI Stock Analysis
Yip's Chemical Holdings
(HKEX:0408)
The score is primarily constrained by declining revenue, low margins, and uneven cash generation. Balance-sheet deleveraging and attractive valuation provide meaningful support, while generally favorable price positioning is offset by mixed momentum indicators.
Yip's Chemical Holdings (0408) vs. iShares MSCI Hong Kong ETF (EWH)
- Market Cap
- HKD 167.54M
- Dividend Yield
- 7.72%
- Average Volume (3M)
- 117.56K
- Price to Earnings (P/E)
- 6.7
- Beta (1Y)
- 0.44
- Revenue Growth
- 6.66%
- EPS Growth
- 65.39%
- Country
- Hong Kong
- Employees
- 2,217
- Sector
- General
- Sector Strength
- 55
- Industry
- Chemicals - Specialty
Yip's Chemical Holdings Business Overview & Revenue Model
Company Description
Yip's Chemical Holdings Limited operates as an investment holding company, engaging in the manufacturing and worldwide distribution of petrochemical products across mainland China, Hong Kong, and other international regions. Its operations are organi...
Yip's Chemical Holdings Financial Statement Overview
Summary
Deleveraging and a stronger balance sheet provide stability, but persistent revenue declines, thin profitability, and volatile cash flow materially weaken overall financial performance.
Income Statement
45NeutralBalance Sheet
72PositiveCash Flow
55Neutral| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 3.24B | 2.99B | 3.16B | 3.22B | 3.36B | 3.99B |
| Gross Profit | 854.87M | 759.15M | 743.65M | 782.27M | 717.73M | 832.83M |
| EBITDA | 143.49M | 131.98M | 117.19M | 183.22M | 56.29M | 174.21M |
| Net Income | 212.42M | 137.41M | 96.88M | 86.62M | 1.22B | 406.28M |
Balance Sheet | ||||||
| Total Assets | 7.01B | 6.84B | 6.08B | 6.42B | 8.01B | 10.42B |
| Cash, Cash Equivalents and Short-Term Investments | 515.82M | 782.80M | 594.38M | 854.25M | 1.09B | 783.35M |
| Total Debt | 1.34B | 1.28B | 1.24B | 1.44B | 2.22B | 2.28B |
| Total Liabilities | 2.63B | 2.68B | 2.26B | 2.50B | 3.55B | 5.69B |
| Stockholders Equity | 4.24B | 4.02B | 3.79B | 3.93B | 4.41B | 3.80B |
Cash Flow | ||||||
| Free Cash Flow | 143.51M | 75.11M | 46.34M | 204.68M | 186.57M | -254.15M |
| Operating Cash Flow | 184.71M | 123.47M | 86.55M | 236.54M | 373.01M | 266.37M |
| Investing Cash Flow | -238.01M | 50.32M | 226.06M | 655.38M | 77.53M | -316.56M |
| Financing Cash Flow | 122.80M | -73.91M | -319.25M | -1.34B | -147.38M | 230.99M |
Yip's Chemical Holdings Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:0408, the sentiment is Positive. The current price of 2.59 is above the 20-day moving average (MA) of 2.57, below the 50-day MA of 2.59, and above the 200-day MA of 2.24, indicating a neutral trend. The MACD of -0.00 indicates Negative momentum. The RSI at 51.91 is Neutral, neither overbought nor oversold. The STOCH value of 53.85 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for HK:0408.
Yip's Chemical Holdings Peers Comparison
Overall Rating
HK:040862Neutral
HK:033661Neutral
HK:331853Neutral
HK:054652Neutral
HK:250250.5Neutral
HK:030143Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 62Neutral | HKD 1.44B | 6.74 | 5.15% | 7.72% | 6.66% | 65.39% | |
| 61Neutral | HKD 10.63B | -21.80 | -3.56% | 0.36% | 13.49% | -34.73% | |
| Sector * | 55Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |
| 53Neutral | HKD 3.43B | -2.77 | -51.09% | ― | 11.19% | -3035.78% | |
| 52Neutral | HKD 10.23B | 0.24 | 5.20% | 4.00% | 1.18% | -65.68% | |
| 51Neutral | HKD 852.91M | 18.38 | 2.33% | ― | -4.75% | ― | |
| 43Neutral | HKD 3.75B | -203.69 | -8.09% | ― | 3.15% | 50.74% |
* General Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| HK:0408 | Yip's Chemical Holdings | 2.59 | 0.74 | 39.92% | |
| HK:0336 | Huabao International Holdings | 3.29 | -0.33 | -9.03% | |
| HK:3318 | China Boton Group Co., Ltd. | 3.19 | 1.48 | 86.55% | |
| HK:0546 | Fufeng Group Limited | 4.00 | -3.93 | -49.54% | |
| HK:0301 | SANVO Fine Chemicals Group Limited | 8.04 | 6.54 | 432.78% | |
| HK:2502 | Henan Jinyuan Hydrogenated Chemicals Co., Ltd. Class H | 0.51 | 0.09 | 21.43% |
Yip's Chemical Holdings Corporate Events
Yip’s Chemical Tightens Governance With Updated Remuneration Committee Mandate
Yip’s Chemical Holdings has updated the terms of reference for its Remuneration Committee, reaffirming its constitution, membership requirements, and meeting procedures, including at least annual meetings and defined quorum and secretarial support. T...
Yip’s Chemical Delivers 113% Profit Surge on Portfolio Optimisation and Strong Inks, Solvents Performance
Yip’s Chemical Holdings reported a strong interim performance for the six months to 30 June 2026, as portfolio optimisation and disciplined operations helped offset macroeconomic and supply chain pressures linked to the US-Iran conflict. The Hong Kon...
Yip’s Chemical Declares Interim Cash Dividend for First Half of 2026
Yip’s Chemical Holdings Limited, a Hong Kong-listed chemical manufacturer, provides chemical products to industrial and commercial users in regional markets. Its board includes a chairman, deputy chairman, chief executive officer, chief financial off...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Nov 07, 2026
